MAZZOTTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 705
EU - Europa 240
AS - Asia 33
AF - Africa 12
SA - Sud America 4
OC - Oceania 1
Totale 995
Nazione #
US - Stati Uniti d'America 687
IT - Italia 101
FR - Francia 66
DE - Germania 34
CA - Canada 18
IN - India 12
ZA - Sudafrica 11
GB - Regno Unito 6
CN - Cina 5
FI - Finlandia 5
NL - Olanda 4
SE - Svezia 4
AE - Emirati Arabi Uniti 3
ES - Italia 3
PH - Filippine 3
RU - Federazione Russa 3
UA - Ucraina 3
BE - Belgio 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HK - Hong Kong 2
KR - Corea 2
PE - Perù 2
PL - Polonia 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 995
Città #
Santa Cruz 94
Fairfield 60
Ashburn 59
Rome 54
Seattle 51
Buffalo 42
Woodbridge 37
Houston 26
Wilmington 26
Cambridge 20
Boardman 14
Columbus 14
Des Moines 12
Ann Arbor 10
Muizenberg 9
Paris 9
Bremen 8
Chicago 7
Clearwater 7
Toronto 6
Bad Kreuznach 5
Helsinki 5
Ottawa 5
Andover 4
Dallas 4
Las Vegas 4
Mumbai 4
New York 4
Phoenix 4
San Diego 4
Stockholm 4
Gibsons 3
Los Angeles 3
Reston 3
San Jose 3
Amsterdam 2
Barcelona 2
Büdelsdorf 2
Cedar Knolls 2
Fleming Island 2
Frankfurt am Main 2
Genoa 2
Ipswich 2
Malo 2
Melegnano 2
Miami 2
Milan 2
Milton 2
Mountain View 2
New Delhi 2
Nutley 2
Pietra Ligure 2
Saint Louis 2
San Francisco 2
Warsaw 2
A Coruña 1
Abidjan 1
Amman 1
Anzio 1
Aprilia 1
Atherstone 1
Atlanta 1
Auckland 1
Augusta 1
Austin 1
Avigliano 1
Bad Bramstedt 1
Bari 1
Beijing 1
Bergamo 1
Birmingham 1
Bologna 1
Brescia 1
Brooklyn 1
Bryanston 1
Cesano Boscone 1
Chandigarh 1
Changchun 1
Charlotte 1
Claye-souilly 1
Colombes 1
Crugers 1
Delhi 1
Drogenbos 1
Eppstein 1
Exeter 1
Falkenstein 1
Fiumicino 1
Frankfurt Am Main 1
Groningen 1
Gunzenhausen 1
Hamilton 1
Herndon 1
Huancayo 1
Irgoli 1
Istanbul 1
Jacksonville 1
Jakarta 1
Karachi 1
Kirkland 1
Totale 709
Nome #
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives, file e3835326-cb79-15e8-e053-a505fe0a3de9 115
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study, file e3835321-b842-15e8-e053-a505fe0a3de9 110
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting, file e3835323-1887-15e8-e053-a505fe0a3de9 95
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab, file e3835322-fdd0-15e8-e053-a505fe0a3de9 91
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab, file e3835323-37d4-15e8-e053-a505fe0a3de9 90
Role of chemotherapy in vulvar cancers: time to rethink standard of care?, file e383532d-39c4-15e8-e053-a505fe0a3de9 86
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer, file e3835322-acbf-15e8-e053-a505fe0a3de9 64
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e3835322-d440-15e8-e053-a505fe0a3de9 60
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: A single-center experience and review of the literature, file e3835329-b093-15e8-e053-a505fe0a3de9 59
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials, file e383532b-35b3-15e8-e053-a505fe0a3de9 57
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes, file e3835328-2476-15e8-e053-a505fe0a3de9 46
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial, file e383532d-1991-15e8-e053-a505fe0a3de9 41
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience, file 45f6d0d2-c79f-4c8b-a254-29e4d8fe77a0 33
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives, file e383532e-e0a7-15e8-e053-a505fe0a3de9 18
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting, file e383532e-fa2b-15e8-e053-a505fe0a3de9 17
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives, file 28d040f3-75f0-4669-9847-0444212b96d4 12
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial, file 414ca0a4-8e30-4a18-94ef-25ad85b00f14 11
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study, file a4d4c711-927f-4aaf-9908-49639ba20321 11
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting, file e383532a-6618-15e8-e053-a505fe0a3de9 8
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting. a survey about Italian physicians’ practice, file 8e0a0d18-3d58-499f-961f-3eeb369b1353 5
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden, file e3835329-7ad4-15e8-e053-a505fe0a3de9 5
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives, file a2ffb1cb-4a5c-4324-8874-5939bf90a4a8 4
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification, file e3835325-41ee-15e8-e053-a505fe0a3de9 4
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma, file 97c00dd2-98c1-467d-aa5b-536dc05e01d6 2
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists, file e383532f-2e8a-15e8-e053-a505fe0a3de9 2
The use of fentanyl in pain management in head and neck cancer patients. a narrative review, file e2f34507-f379-4a2a-824f-7f65b8d5206b 1
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy, file e383532d-1993-15e8-e053-a505fe0a3de9 1
Totale 1.048
Categoria #
all - tutte 2.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 1 4
2019/2020135 3 3 9 5 19 14 16 15 18 13 12 8
2020/2021225 17 6 13 16 4 18 15 22 16 63 21 14
2021/2022248 8 10 16 5 20 13 12 15 8 15 87 39
2022/2023273 26 8 71 54 27 26 19 13 3 5 19 2
2023/2024162 2 10 16 12 33 26 18 24 3 4 14 0
Totale 1.048